Jeena Sikho Lifecare Limited has informed the Exchange about Publication of Case Studies and Case Report.
JSLL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jeena Sikho Lifecare has informed the exchanges about the publication of five case studies and one case report in two academic journals — the International Journal of Advanced Research (IJAR) and the Journal of Ayurveda and Integrated Medical Sciences (JAIMS). The publications were authored by medical professionals associated with the company, including Managing Director Manish Grover, senior consultants, and Ayurvedic experts. The studies cover Ayurvedic treatment approaches for conditions such as fatty liver with dyslipidemia, chronic kidney disease, Type 2 diabetes, and chronic liver disease. The company stated this reflects its commitment to Ayurvedic research and evidence-based clinical practice.
This is a research and brand-building announcement with no direct financial or commercial impact. It may modestly support the company's credibility in the Ayurvedic healthcare space but is unlikely to move the stock meaningfully.